RogerBLeeMD

PubMed

• Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
  Aaron M Praiss, Austin Miller, Judith Smith, Stuart M Lichtman, Michael Bookman, Carol Aghajanian, Paul Sabbatini, Floor Backes, David E Cohn, Peter Argenta, Michael F...> ;Gynecologic Oncology. 2023 Jul 1
• 8 citations
  The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS...
  Nick M. Spirtos, Danielle Enserro, Howard D. Homesley, Susan K. Gibbons, David Cella, Robert T. Morris, Koen DeGeest, Roger B. Lee, David Miller> ;Gynecologic Oncology. 2019 Jul 1
• 30 citations
  Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
  Peter G. Rose, James J. Java, Ritu Salani, Melissa A. Geller, Angeles Alvarez Secord, Krishnansu S. Tewari, David Bender, David G. Mutch, Michael Friedlander, Linda Va...> ;Obstetrics and Gynecology. 2019 Feb 1
• 2 citations
  Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gy...
  Alexander B. Olawaiye, James J. Java, Thomas C. Krivak, Michael Friedlander, David G. Mutch, Gretchen E. Glaser, Melissa A. Geller, David M. O'Malley, Robert M. Wenham...> ;Gynecologic Oncology. 2019 Jan 1
• 14 citations
  Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncolo...
  Alexander B. Olawaiye, James J. Java, Thomas C. Krivak, Michael Friedlander, David G. Mutch, Gretchen E. Glaser, Melissa A. Geller, David M. O'Malley, Robert M. Wenham...> ;Gynecologic Oncology. 2018 Oct 1
• 13 citations
  Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
  Neil S. Horowitz, G. Larry Maxwell, Austin Miller, Chad A. Hamilton, Bunja Rungruang, Noah Rodriguez, Scott D. Richard, Thomas C. Krivak, Jeffrey M. Fowler, David G. M...> ;Gynecologic Oncology. 2018 Jan 1
• 5 citations
  Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An N...
  Kathleen N. Moore, D. Tritchler, Kenneth M. Kaufman, Heather A. Lankes, Michael C.J. Quinn, Linda Van Le, Andrew Berchuck, Floor J. Backes, Krishnansu S. Tewari, Roger...> ;Gynecologic Oncology. 2014 Jun 1
• 48 citations
  A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-...
  Robert S. Mannel, Mark F. Brady, Elise C. Kohn, Parviz Hanjani, Masamichi Hiura, Roger B. Lee, Koen DeGeest, David E. Cohn, Bradley J. Monk, Helen Michael> ;Gynecologic Oncology. 2011 Jul 1
• 26 citations
  Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184
  David Cella, Helen Q. Huang, Howard D. Homesley, Anthony G. Montag, Ritu Salani, Koen De Geest, Roger B. Lee, Nick M. Spirtos> ;Gynecologic Oncology. 2010 Dec 1
• 156 citations
  A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxe...
  Howard D. Homesley, Virginia L. Filiaci, Susan K. Gibbons, Harry J. Long, David Cella, Nick M. Spirtos, Robert T. Morris, Koen DeGeest, Roger B. Lee, Anthony G. Montag> ;Gynecologic Oncology. 2009 Mar 1
• 81 citations
  Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group S...
  Russell J. Schilder, Michael W. Sill, Roger B. Lee, Tanya J. Shaw, Mary K. Senterman, Andres J. Klein-Szanto, Zoe Miner, Barbara C. Vanderhyden> ;Journal of Clinical Oncology. 2008 Jul 10
• 42 citations
  Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
  David R. Spriggs, Mark F. Brady, Luis Vaccarello, Daniel L. Clarke-Pearson, Robert A. Burger, Robert S. Mannel, John F. Boggess, Roger B. Lee, Mark G. Hanly> ;Journal of Clinical Oncology. 2007 Oct 1
• 65 citations
  Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: A phase II study of the Gynecologic Oncol...
  Gregory P. Sutton, Janice H. Axelrod, Brian N. Bundy, Tapan Roy, Howard D. Homesley, Roger B. Lee, Paola A. Gehrig, Richard J. Zaino> ;Gynecologic Oncology. 2006 Feb 1
• 195 citations
  Phase II Study of Gefitinib in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma and Evaluation of Epidermal Growth Factor Receptor Mutation...
  Russell J. Schilder, Michael W. Sill, Xiaowei Chen, Kathleen M. Darcy, Steven L. Decesare, George Lewandowski, Roger B. Lee, Cletus A. Arciero, Hong Wu, Andrew K. Godwin> ;Clinical Cancer Research. 2005 Aug 1
• 119 citations
  Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
  Charles W. Whitney, Virginia L. Brunetto, Richard J. Zaino, Samuel S. Lentz, Joel I. Sorosky, Deborah K. Armstrong, Roger B. Lee> ;Gynecologic Oncology. 2004 Jan 1
• 123 citations
  Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study
  Sarah Lincoln, John A. Blessing, Roger B Lee, Thomas F Rocereto> ;Gynecologic Oncology. 2003 Mar 1
• 45 citations
  Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
  Robert F. Asbury, Virginia L. Brunetto, Roger B. Lee, Gary C. Reid, Thomas F. Rocereto> ;American Journal of Clinical Oncology. 2002 Dec 1
• 132 citations
  A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : a Gynecologic Oncology Group study
  Peter G. Rose, Virginia L. Brunetto, Linda VanLe, Jeffrey Bell, Joan L. Walker, Roger B. Lee> ;Gynecologic Oncology. 2000 Aug 1
• 17 citations
  Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
  William A. Peters, Michael R. Smith, Joanna M. Cain, Roger B. Lee, Joseph L. Yon> ;Gynecologic Oncology. 1992 Nov 1
• 62 citations
  Surgical complications of obese patients with endometrial carcinoma.
  Katherine S. Foley, Roger B. Lee> ;Gynecologic Oncology. 1990 Nov 1
• 21 citations
  Stage IA2 squamous carcinoma of the cervix: difficult diagnosis and therapeutic dilemma.
  Benjamin E. Greer, David C. Figge, Hisham K. Tamimi, Joanna M. Cain, Roger B. Lee> ;American Journal of Obstetrics and Gynecology. 1990 Jun 1
• 7 citations
  Pregnancy following conservative surgery and adjunctive chemotherapy for stage III immature teratoma of the ovary.
  Roger B. Lee, Kelly J, Elg Sa, Benson Wl> ;Obstetrics and Gynecology. 1989 May 1
• Join now to see all